Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods

肉汤微量稀释 替加环素 微生物学 头孢吡肟 美罗培南 亚胺培南 生物 医学 抗生素 抗生素耐药性 最小抑制浓度
作者
Shu‐Chen Kuo,Mei-Chen Tan,Wei‐Cheng Huang,Han Chieh Wu,Feng-Jui Chen,Yu-Chieh Liao,Huiying Wang,Yih-Ru Shiau,Tsai‐Ling Lauderdale
出处
期刊:Journal of Antimicrobial Chemotherapy [Oxford University Press]
卷期号:76 (3): 653-658 被引量:16
标识
DOI:10.1093/jac/dkaa499
摘要

Abstract Objectives We aimed to determine susceptibilities of Elizabethkingia spp. to 25 commonly tested and 8 novel antibiotics, and to compare the performance of different susceptibility testing methods. Methods Clinical isolates of Elizabethkingia spp., Chryseobacterium spp. and Flavobacterium spp. collected during 2002–18 (n = 210) in a nationwide surveillance programme in Taiwan were speciated by 16S rRNA sequencing. MICs were determined by broth microdilution. The broth microdilution results of 18 common antibiotics were compared with those obtained by the VITEK 2 automated system. Results Among the Elizabethkingia spp. identified (n = 108), Elizabethkingia anophelis was the most prevalent (n = 90), followed by Elizabethkingia meningoseptica (n = 7) and Elizabethkingia miricola cluster [E. miricola (n = 6), Elizabethkingia bruuniana (n = 3) and Elizabethkingia ursingii (n = 2)]. Most isolates were recovered from respiratory or blood specimens from hospitalized, elderly patients. PFGE showed two major and several minor E. anophelis clones. All isolates were resistant to nearly all the tested β-lactams. Doxycycline, minocycline and trimethoprim/sulfamethoxazole inhibited >90% of Elizabethkingia spp. Rifampin inhibited E. meningoseptica (100%) and E. anophelis (81.1%). Fluoroquinolones and tigecycline were active against E. meningoseptica and E. miricola cluster isolates. Novel antibiotics, including imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam, delafloxacin, eravacycline and omadacycline were ineffective but lascufloxacin inhibited half of Elizabethkingia spp. The very major discrepancy rates of VITEK 2 were >1.5% for ciprofloxacin, moxifloxacin and vancomycin. Major discrepancy rates were >3% for amikacin, tigecycline, piperacillin/tazobactam and trimethoprim/sulfamethoxazole. Conclusions MDR, absence of standard interpretation criteria and poor intermethod concordance necessitate working guidelines to facilitate future research of emerging Elizabethkingia spp.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的小迷弟应助11111采纳,获得10
1秒前
单纯黑米完成签到,获得积分10
3秒前
科研通AI6.4应助小分队采纳,获得10
3秒前
lizishu应助蓝天采纳,获得10
5秒前
Nole应助蓝天采纳,获得30
5秒前
烟花应助蓝天采纳,获得30
5秒前
六六完成签到,获得积分10
6秒前
qiaoxi完成签到,获得积分10
6秒前
boss_astr完成签到,获得积分10
8秒前
8秒前
强壮的美女完成签到,获得积分10
10秒前
12秒前
boss_phy完成签到,获得积分10
13秒前
mikejefy完成签到,获得积分10
14秒前
coasting完成签到,获得积分10
14秒前
TheGreat完成签到,获得积分10
15秒前
炙热的彤发布了新的文献求助10
16秒前
16秒前
lin0u0完成签到,获得积分10
17秒前
无情的聪健应助Jessy畅畅采纳,获得20
19秒前
19秒前
严涵完成签到,获得积分10
20秒前
83366完成签到,获得积分10
20秒前
11111完成签到,获得积分10
21秒前
咯咚完成签到 ,获得积分10
21秒前
期刊发布了新的文献求助10
23秒前
3G就是牛应助科研通管家采纳,获得10
23秒前
李健应助科研通管家采纳,获得10
23秒前
23秒前
23秒前
dzzza完成签到,获得积分10
23秒前
汉堡包应助科研通管家采纳,获得10
24秒前
24秒前
11111发布了新的文献求助10
24秒前
Jasper应助科研通管家采纳,获得10
24秒前
丘比特应助科研通管家采纳,获得10
24秒前
小小智留下了新的社区评论
24秒前
路豐遙完成签到,获得积分10
25秒前
CipherSage应助韶华采纳,获得10
25秒前
qqq完成签到 ,获得积分0
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Periodic Report Summary 2 - AFTER (A Framework for electrical power sysTems vulnerability identification, dEfense and Restoration) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7318761
求助须知:如何正确求助?哪些是违规求助? 8934459
关于积分的说明 18939020
捐赠科研通 6977500
什么是DOI,文献DOI怎么找? 3214255
关于科研通互助平台的介绍 2382228
邀请新用户注册赠送积分活动 2193246